SEC Form 4 · accession 0001144204-16-080889
Alliqua BioMedical, Inc. · ALQA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian M Posner
Officer — Chief Financial Officer
Period of report
Feb 9, 2016
Accepted (ET)
Feb 11, 2016 · 4:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001054274
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 9, 2016 | A | 24,658 | $0.00 | A | 141,539 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a restricted stock award portion of Mr. Posner's 2015 bonus amount based on the value of the Issuer's common stock on the date of grant. This award is subject to forfeiture until vested, with 100% vesting on February 9, 2017, subject to Mr. Posner's continued service through the applicable vesting date and the terms and conditions of the Alliqua BioMedical, Inc. 2014 Long-Term Incentive Plan and that certain restricted stock award agreement by and between the Issuer and Mr. Posner, effective as of February 9, 2016.